{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T22:15:11Z","timestamp":1777414511517,"version":"3.51.4"},"reference-count":12,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Emergency Medicine"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1016\/j.ajem.2008.12.013","type":"journal-article","created":{"date-parts":[[2009,9,23]],"date-time":"2009-09-23T10:46:05Z","timestamp":1253702765000},"page":"1018.e1-1018.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Haloperidol-induced neuroleptic malignant syndrome complicated by hyperosmolar hyperglycemic state"],"prefix":"10.1016","volume":"27","author":[{"given":"Wasseem","family":"Rock","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mazen","family":"Elias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ami","family":"Lev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walid R.","family":"Saliba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.ajem.2008.12.013_bib1","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1176\/ajp.142.10.1137","article-title":"Neuroleptic malignant syndrome","volume":"142","author":"Levenson","year":"1985","journal-title":"Am J Psychiatry"},{"issue":"5","key":"10.1016\/j.ajem.2008.12.013_bib2","first-page":"208","article-title":"Neuroleptic malignant syndrome: long-term follow-up of 20 cases","volume":"52","author":"Pope","year":"1991","journal-title":"J Clin Psychiatry"},{"issue":"10","key":"10.1016\/j.ajem.2008.12.013_bib3","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1001\/archpsyc.1989.01810100056011","article-title":"Risk factors for neuroleptic malignant syndrome. A case-control study","volume":"46","author":"Keck","year":"1989","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"10.1016\/j.ajem.2008.12.013_bib4","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/bja\/85.1.129","article-title":"Neuroleptic malignant syndrome","volume":"85","author":"Adent","year":"2000","journal-title":"Br J Anesth"},{"issue":"1","key":"10.1016\/j.ajem.2008.12.013_bib5","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2165\/00002018-199819010-00006","article-title":"Neuroleptic malignant syndrome. Recognition, prevention and management","volume":"19","author":"Velamoor","year":"1998","journal-title":"Drug Saf"},{"issue":"2","key":"10.1016\/j.ajem.2008.12.013_bib6","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00004583-199902000-00018","article-title":"Neuroleptic malignant syndrome in children and adolescents","volume":"38","author":"Silva","year":"1999","journal-title":"J Am Acad Child Adolsc Psychiatry"},{"issue":"1","key":"10.1016\/j.ajem.2008.12.013_bib7","first-page":"18","article-title":"Mortality from neuroleptic malignant syndrome","volume":"50","author":"Shalev","year":"1989","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.ajem.2008.12.013_bib8","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1192\/bjp.161.2.257","article-title":"Neuroleptic malignant syndrome presenting as hyperosmolar non-ketotic diabetic coma","volume":"161","author":"Balzan","year":"1992","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.ajem.2008.12.013_bib9","article-title":"Olanzapine-induced hyperglycemic coma and neuroleptic malignant syndrome: case report and review of literature","author":"Ahuja","year":"2008","journal-title":"Psychopharmacol"},{"issue":"8","key":"10.1016\/j.ajem.2008.12.013_bib10","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/S0006-3223(97)00530-1","article-title":"Clinical and pharmacologic risk factors for neuroleptic malignant syndrome: a case control study","volume":"44","author":"Berardi","year":"1998","journal-title":"Biol Psychiatry"},{"issue":"4","key":"10.1016\/j.ajem.2008.12.013_bib11","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/00002826-200207000-00001","article-title":"Is neuroleptic syndrome a neurogenic form of malignant hyperthermia?","volume":"25","author":"Gurrera","year":"2002","journal-title":"Clin Neuropharmacol"},{"issue":"25","key":"10.1016\/j.ajem.2008.12.013_bib12","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1056\/NEJM198106183042504","article-title":"Glucagon and the A cell. Physiology and pathophysiology","volume":"304","author":"Unger","year":"1981","journal-title":"N Engl J Med"}],"container-title":["The American Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675708008309?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675708008309?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T15:12:37Z","timestamp":1760022757000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735675708008309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":12,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S0735675708008309"],"URL":"https:\/\/doi.org\/10.1016\/j.ajem.2008.12.013","relation":{},"ISSN":["0735-6757"],"issn-type":[{"value":"0735-6757","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Haloperidol-induced neuroleptic malignant syndrome complicated by hyperosmolar hyperglycemic state","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajem.2008.12.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}